Marianne Borgers

Beerse, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Development and Characterization of Mouse-Specific Anti-Tau Monoclonal Antibodies: Relevance for Analysis of Murine Tau in Cerebrospinal Fluid.

Development and Characterization of Mouse-Specific Anti-Tau Monoclonal Antibodies: Relevance for Analysis of Murine Tau in Cerebrospinal Fluid.

Journal: Journal of Alzheimer's disease : JAD

Published: March 27, 2023

Passive immunotherapy with a novel antibody against 3pE-modified Aβ demonstrates potential for enhanced efficacy and favorable safety in combination with BACE inhibitor treatment in plaque-depositing mice.

Passive immunotherapy with a novel antibody against 3pE-modified Aβ demonstrates potential for enhanced efficacy and favorable safety in combination with BACE inhibitor treatment in plaque-depositing mice.

Journal: Neurobiology of disease

Published: February 15, 2021

Discovery and Functional Characterization of hPT3, a Humanized Anti-Phospho Tau Selective Monoclonal Antibody.

Discovery and Functional Characterization of hPT3, a Humanized Anti-Phospho Tau Selective Monoclonal Antibody.

Journal: Journal of Alzheimer's disease : JAD

Published: September 07, 2020

Neural oscillations during cognitive processes in an App knock-in mouse model of Alzheimer's disease pathology.

Neural oscillations during cognitive processes in an App knock-in mouse model of Alzheimer's disease pathology.

Journal: Scientific reports

Published: August 02, 2019

Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo.

Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo.

Journal: Journal of Alzheimer's disease : JAD

Published: July 25, 2018

Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser422 containing epitope on pathological tau.

Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser422 containing epitope on pathological tau.

Journal: Acta neuropathologica communications

Published: May 31, 2018

A common antigenic motif recognized by naturally occurring human VH5-51/VL4-1 anti-tau antibodies with distinct functionalities.

A common antigenic motif recognized by naturally occurring human VH5-51/VL4-1 anti-tau antibodies with distinct functionalities.

Journal: Acta neuropathologica communications

Published: April 06, 2018

Using Human iPSC-Derived Neurons to Model TAU Aggregation.

Using Human iPSC-Derived Neurons to Model TAU Aggregation.

Journal: PloS one

Published: September 19, 2015

Erratum to: Acute function of secreted amyloid precursor protein fragment APPsα in synaptic plasticity.

Erratum to: Acute function of secreted amyloid precursor protein fragment APPsα in synaptic plasticity.

Journal: Acta neuropathologica

Published: December 21, 2014

Acute function of secreted amyloid precursor protein fragment APPsα in synaptic plasticity.

Acute function of secreted amyloid precursor protein fragment APPsα in synaptic plasticity.

Journal: Acta neuropathologica

Published: August 13, 2014

Soluble amyloid-β precursor protein binds its cell surface receptor in a cooperative fashion with glypican and syndecan proteoglycans.

Soluble amyloid-β precursor protein binds its cell surface receptor in a cooperative fashion with glypican and syndecan proteoglycans.

Journal: Journal of cell science

Published: August 30, 2013

Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

Journal: Science (New York, N.Y.)

Published: May 25, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026